This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Food and Drug Administration warned today that patients taking the ...
WASHINGTON, Dec 10 (Reuters) - U.S. regulators gave a clean bill of health to AstraZeneca Plc's Prilosec and Nexium on Monday, saying they found no evidence of an increased risk of heart problems from ...
WASHINGTON (Reuters) - U.S. regulators said on Monday they had cleared AstraZeneca Plc's best-selling heartburn drugs Prilosec and Nexium of links to heart problems, but disclosed a review of a ...
WASHINGTON -- Federal regulators Thursday said they have opened a safety investigation of two popular heartburn drugs -- Nexium, marketed as the "purple pill," and Prilosec, its older chemical cousin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback